|
Market Closed -
Nasdaq
16:00:00 2026-08-31 EDT
|
5-day change | 1st Jan Change | ||
| 23.97 USD | +0.80% |
|
-3.27% | -17.46% |
| 08-24 | Oruka Therapeutics Names Chief Commercial Officer | MT |
| 08-20 | Arcutis Biotherapeutics' Zoryve Gets Health Canada Approval for Children With Atopic Dermatitis | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.80% | -3.27% | -10.76% | +11.64% | -17.46% | +56.46% | +180.68% | +13.23% | - | 3.01B | |
| +0.62% | -3.55% | +4.78% | +33.03% | +3.53% | +38.27% | -3.32% | +18.66% | +103.56% | 79.79B | |
| +0.43% | +1.89% | +40.02% | +82.92% | -0.20% | -18.05% | -37.01% | -44.76% | +59.40% | 58.85B | |
| +1.70% | +1.04% | +156.00% | +204.69% | +375.89% | +480.16% | +24.12% | -62.74% | - | 56.03B | |
| +2.15% | -2.13% | -0.59% | +11.37% | -10.44% | -1.37% | +30.77% | +4.25% | - | 51.26B | |
| +1.02% | -1.14% | -2.42% | -14.44% | -8.84% | +9.19% | +162.68% | +124.50% | +195.48% | 47.68B | |
| -0.85% | -0.67% | +6.75% | +12.70% | +23.10% | +55.16% | -18.97% | -36.07% | -29.11% | 32.01B | |
| -0.92% | -3.72% | +3.10% | +28.90% | +24.75% | +43.31% | +90.95% | +61.09% | +51.94% | 24.98B | |
| -1.93% | +2.31% | +17.42% | +25.83% | +33.51% | -3.42% | +190.03% | +62.36% | - | 23.05B | |
| +1.31% | +1.11% | -2.89% | +5.25% | +37.32% | +61.48% | +115.97% | +143.15% | +351.58% | 16.31B | |
| -3.91% | -3.91% | +43.02% | +8.33% | -11.07% | -8.84% | +773.77% | +492.95% | +7,140.75% | 15.64B | |
| -0.01% | -5.53% | -4.37% | +17.18% | +0.13% | +53.18% | +156.07% | +52.84% | - | 14.97B | |
| +0.87% | +0.25% | +8.68% | +18.54% | +9.76% | +10.39% | -28.62% | -22.54% | -30.53% | 12.63B | |
| -0.25% | -3.35% | -8.93% | -13.78% | +8.69% | +60.78% | +145.69% | +673.05% | +2,641.99% | 10.4B | |
| +2.25% | +5.16% | +5.35% | +20.55% | +45.76% | +141.18% | +188.69% | +520.23% | - | 10.64B | |
| -1.68% | -1.28% | +51.83% | +104.83% | +338.21% | +429.73% | +532.11% | +22.78% | - | 8.72B | |
| -0.42% | -0.75% | -1.59% | +6.49% | -8.36% | -19.36% | -22.45% | -52.61% | -48.36% | 6.82B | |
| -2.06% | +0.73% | +1.52% | +31.85% | +1.26% | -5.48% | +60.30% | -14.74% | - | 6.1B | |
| +0.70% | -0.94% | +5.77% | +62.36% | +90.62% | +129.38% | +356.36% | +525.04% | - | 6.14B | |
| -4.54% | -5.23% | -5.39% | -16.36% | -35.49% | -50.56% | -42.82% | -73.83% | - | 5.45B | |
| Average | -0.41% | -0.68% | +15.36% | +32.10% | +45.03% | +73.08% | +142.75% | +120.34% | +1,043.67% | 24.52B | |
| Weighted average by Cap. | -0.03% | -1.25% | +26.68% | +46.62% | +54.74% | +82.01% | +83.85% | +59.11% | +542.77% |
- Stock Market
- Stocks
- ARQT Stock
- Sector Arcutis Biotherapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
